Literature DB >> 20692015

Occurrence and fate of oseltamivir carboxylate (Tamiflu) and amantadine in sewage treatment plants.

Gopal Chandra Ghosh1, Norihide Nakada, Naoyuki Yamashita, Hiroaki Tanaka.   

Abstract

We investigated the occurrence and fate of the two antiviral drugs oseltamivir carboxylate (OC)-the active metabolite of Tamiflu-and amantadine (AMT) at three sewage treatment plants (STPs) during the 2008-2009 and 2009-2010 influenza seasons in Japan. Both compounds were detected in all samples analyzed. The concentrations in raw influents at the STPs ranged from 140 to 460 ng L(-1) OC and from 184 to 538 ng L(-1) AMT. Primary treatment gave no substantial removal of the drugs (OC, 2-9%; AMT, 7-17%). Biological nutrient-removal-based secondary treatment (anoxic-oxic-anoxic-oxic and anaerobic-anoxic-oxic) removed 20-37% of OC, whereas extended-aeration-based conventional activated sludge treatment removed <20%. STPs using primary plus biological secondary treatment removed <50% of the drugs. The incorporation of tertiary treatment by ozonation removed >90%. Ozonation after secondary treatment in STPs will be necessary during an influenza pandemic to reduce the risks associated with the widespread use of antiviral drugs. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692015     DOI: 10.1016/j.chemosphere.2010.07.023

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  9 in total

1.  Susceptibility of avian influenza viruses of the N6 subtype to the neuraminidase inhibitor oseltamivir.

Authors:  Terri D Stoner; Scott Krauss; Jasmine C M Turner; Patrick Seiler; Nicholas J Negovetich; David E Stallknecht; Sharon Frase; Elena A Govorkova; Robert G Webster
Journal:  Antiviral Res       Date:  2012-01-10       Impact factor: 5.970

2.  Oseltamivir-resistant influenza A (H1N1) virus strain with an H274Y mutation in neuraminidase persists without drug pressure in infected mallards.

Authors:  Anna Gillman; Shaman Muradrasoli; Hanna Söderström; Fredrik Holmberg; Neus Latorre-Margalef; Conny Tolf; Jonas Waldenström; Gunnar Gunnarsson; Björn Olsen; Josef D Järhult
Journal:  Appl Environ Microbiol       Date:  2015-01-23       Impact factor: 4.792

3.  Influenza A(H7N9) virus acquires resistance-related neuraminidase I222T substitution when infected mallards are exposed to low levels of oseltamivir in water.

Authors:  Anna Gillman; Marie Nykvist; Shaman Muradrasoli; Hanna Söderström; Michelle Wille; Annika Daggfeldt; Caroline Bröjer; Jonas Waldenström; Björn Olsen; Josef D Järhult
Journal:  Antimicrob Agents Chemother       Date:  2015-06-15       Impact factor: 5.191

4.  Intra- and inter-pandemic variations of antiviral, antibiotics and decongestants in wastewater treatment plants and receiving rivers.

Authors:  Andrew C Singer; Josef D Järhult; Roman Grabic; Ghazanfar A Khan; Richard H Lindberg; Ganna Fedorova; Jerker Fick; Michael J Bowes; Björn Olsen; Hanna Söderström
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

5.  Published sequences do not support transfer of oseltamivir resistance mutations from avian to human influenza A virus strains.

Authors:  Peter Norberg; Magnus Lindh; Sigvard Olofsson
Journal:  BMC Infect Dis       Date:  2015-03-28       Impact factor: 3.090

Review 6.  Risk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivir.

Authors:  Anna Gillman
Journal:  Infect Ecol Epidemiol       Date:  2016-10-11

Review 7.  A sustainable approach for the removal methods and analytical determination methods of antiviral drugs from water/wastewater: A review.

Authors:  Bahriye Eryildiz; Bahar Yavuzturk Gul; Ismail Koyuncu
Journal:  J Water Process Eng       Date:  2022-08-08

8.  Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review.

Authors:  Josef D Järhult
Journal:  Infect Ecol Epidemiol       Date:  2012-06-21

Review 9.  COVID-19 drugs in aquatic systems: a review.

Authors:  Willis Gwenzi; Rangabhashiyam Selvasembian; Nnanake-Abasi O Offiong; Alaa El Din Mahmoud; Edmond Sanganyado; Joyabrata Mal
Journal:  Environ Chem Lett       Date:  2022-01-15       Impact factor: 13.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.